Jiangsu Jibeier Pharmaceutical Co., Ltd.
SSE:688566.SS
28.15 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 847.48 | 694.875 | 903.903 | 1,025.04 | 1,287.364 | 193.382 | 124.914 | 201.362 | 133.301 |
| Short Term Investments
| 56 | 35 | 90 | 200 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 903.48 | 729.875 | 993.903 | 1,225.04 | 1,287.364 | 193.382 | 124.914 | 201.362 | 133.301 |
| Net Receivables
| 366.014 | 369.229 | 216.211 | 146.605 | 187.658 | 134.636 | 110.34 | 0 | 112.786 |
| Inventory
| 30.698 | 29.513 | 32.656 | 31.826 | 32.106 | 29.199 | 31.531 | 26.094 | 33.313 |
| Other Current Assets
| 4.241 | 2.538 | 14.003 | 5.143 | 2.761 | 8.226 | 6.101 | 1.697 | 2.595 |
| Total Current Assets
| 1,304.434 | 1,131.155 | 1,256.774 | 1,406.094 | 1,509.889 | 365.443 | 272.886 | 329.364 | 281.994 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 986.858 | 832.486 | 552.212 | 271.509 | 156.803 | 156.907 | 131.094 | 125.966 | 131.304 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 88.449 | 58.205 | 59.739 | 61.275 | 63.03 | 64.509 | 65.764 | 52.733 | 53.989 |
| Goodwill and Intangible Assets
| 88.449 | 58.205 | 59.739 | 61.275 | 63.03 | 64.509 | 65.764 | 52.733 | 53.989 |
| Long Term Investments
| 23.792 | 91.187 | -28.261 | -143.375 | 4.321 | -8.152 | 1.347 | 1.683 | 2.671 |
| Tax Assets
| 17.932 | 16.134 | 15.585 | 11.718 | 10.915 | 6.522 | 6.197 | 2.365 | 11.042 |
| Other Non-Current Assets
| 106.075 | 80.502 | 108.526 | 211.466 | 2.306 | 10.391 | 0.706 | 15.565 | 1.144 |
| Total Non-Current Assets
| 1,223.107 | 1,078.513 | 707.802 | 412.593 | 237.375 | 230.177 | 205.108 | 198.313 | 200.15 |
| Total Assets
| 2,527.541 | 2,209.668 | 1,964.575 | 1,818.687 | 1,747.264 | 595.621 | 477.994 | 527.677 | 482.145 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 97.147 | 91.219 | 101.672 | 69.918 | 25.805 | 31.284 | 22.484 | 20.381 | 19.392 |
| Short Term Debt
| 20.828 | 9.91 | 0 | 0 | 0 | 0 | 0 | 0 | 19 |
| Tax Payables
| 19.415 | 15.907 | 10.129 | 12.538 | 16.501 | 5.764 | 5.058 | 8.1 | 8.307 |
| Deferred Revenue
| 0 | 1.81 | 3.419 | 1.507 | 1.009 | 1.362 | 0.463 | 1.331 | 43.252 |
| Other Current Liabilities
| 47.802 | 91.465 | 69.56 | 40.097 | 41.702 | 28.038 | 33.718 | 23.639 | 35.87 |
| Total Current Liabilities
| 185.192 | 210.312 | 181.362 | 124.06 | 84.008 | 65.085 | 61.26 | 52.12 | 82.569 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 58.589 | 0 | 58.849 | 59.697 | 60.275 | 33.434 | 32.417 | 8.157 | 9.786 |
| Deferred Tax Liabilities Non-Current
| 3.254 | 3.254 | 3.395 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 26.639 | 85.683 | 26.639 | 26.639 | 26.639 | 60.073 | 26.639 | 26.639 | 26.639 |
| Total Non-Current Liabilities
| 88.483 | 88.937 | 88.883 | 86.336 | 86.914 | 60.073 | 59.056 | 34.796 | 36.425 |
| Total Liabilities
| 273.675 | 299.249 | 270.245 | 210.397 | 170.922 | 125.158 | 120.316 | 86.916 | 118.994 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 199.431 | 189.084 | 186.942 | 186.942 | 186.942 | 140.206 | 140.206 | 140.206 | 140.206 |
| Retained Earnings
| 650.059 | 538.854 | 369.277 | 320.147 | 306.761 | 234.782 | 132.706 | 230.332 | 160.038 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 118.844 | 118.74 | 81.424 | 62.308 | 49.435 | 77.916 | 63.679 | 56.449 |
| Other Total Stockholders Equity
| 1,399.148 | 1,058.056 | 1,013.472 | 1,013.472 | 1,013.472 | 88.754 | 77.916 | 63.679 | 56.449 |
| Total Shareholders Equity
| 2,248.637 | 1,904.839 | 1,688.43 | 1,601.985 | 1,569.483 | 463.743 | 350.828 | 434.217 | 356.693 |
| Total Equity
| 2,253.865 | 1,910.419 | 1,694.33 | 1,608.29 | 1,576.342 | 470.463 | 357.678 | 440.761 | 363.15 |
| Total Liabilities & Shareholders Equity
| 2,527.541 | 2,209.668 | 1,964.575 | 1,818.687 | 1,747.264 | 595.621 | 477.994 | 527.677 | 482.145 |